TOPCAT Study Shows Spironolactone Did Not Reduce Primary Outcome, but Did Reduce Hospitalizations for Heart Failure

Spironolactone did not significantly reduce primary endpoint
Source: BWH for Journalists - Category: Research Source Type: news